Brem Foundation Grant

The Brem Foundation to Defeat Breast Cancer is a nonprofit organization dedicated to improving health outcomes through early detection of breast cancer, particularly for underserved populations. Through its B-Fund grant program, the foundation addresses financial barriers that prevent timely access to breast screening and diagnostic services. The organization emphasizes equitable access, innovation, and advocacy, working closely with medical providers to ensure that women receive critical care when it is most effective. The B-Fund has evolved over time, particularly in response to disruptions during the COVID-19 pandemic, to include both diagnostic and screening mammograms as eligible expenses. The primary purpose of the B-Fund grant program is to provide financial support to medical institutions that serve patients experiencing financial hardship and who cannot otherwise access breast diagnostic or screening services. These services are essential when a patient presents with symptoms or receives an abnormal screening result. The program aims to reduce delays in diagnosis, which can significantly impact treatment outcomes and survival rates. By requiring that diagnostic services be delivered within two weeks of abnormal findings or symptom onset, the program reinforces the urgency of early detection. Funding provided through the B-Fund must be used strictly for breast screening and diagnostic procedures, including mammography, ultrasound, MRI, biopsies, molecular imaging, and pathology costs. The grant explicitly prohibits the use of funds for salaries, administrative costs, transportation, equipment, research, or post-diagnosis treatment. Additionally, all services funded must be billed at or below Medicaid negotiated rates, ensuring cost efficiency and alignment with public healthcare standards. Grant funds are intended to be fully utilized within a 12-month period unless otherwise approved. Eligibility for the program is limited to medical centers and nonprofit healthcare providers that either directly offer breast diagnostic and screening services or maintain formal partnerships with entities that do. Applicants must demonstrate a commitment to equitable care regardless of demographic factors and must have an established financial assistance policy. They are also required to show that patients served cannot access other financial assistance programs within two weeks of need. Organizations must actively inform patients about Medicaid and other available programs before utilizing B-Fund resources. The application process requires submission of a comprehensive proposal via email in PDF format. Required components include a statement of need, a detailed plan for the use of funds, projected patient volume, and documentation of adherence to financial assistance policies. Applicants must also provide organizational and contact information. Applications are reviewed by a selection committee, and successful applicants are required to enter into a formal memorandum of understanding with the foundation. Reporting obligations include two detailed reports during the grant cycle, capturing patient demographics, services rendered, and outcomes. The timeline for the 2026 grant cycle begins with the release of the request for proposals on April 8, 2026. Applications are due by May 15, 2026, with award notifications expected by June 15, 2026. Funds are distributed in two installments on July 1, 2026, and December 15, 2026. The grant cycle spans 12 months starting July 1, 2026, with required reports due on January 31, 2027, and July 31, 2027. The program operates on an annual cycle, and no new applications are accepted until prior funds are fully utilized. Overall, the B-Fund grant program represents a targeted and structured effort to eliminate financial barriers to breast healthcare. By partnering with qualified medical providers and enforcing strict usage and reporting requirements, the Brem Foundation ensures that funds are used effectively to deliver timely, lifesaving diagnostic services to women in need.

Ensure strong documentation of patient financial hardship and demonstrate ability to deliver diagnostic services within two weeks; clearly outline projected patient impact and adherence to financial assistance policies